Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe. The company was incorporated in 2014 a…
| Métrica | PLSM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 84.2% | 57.4% | +26.8% |
| Operating Margin | — | -34.4% | — |
| Net Margin | -39.6% | -32.5% | -7.2% |
| FCF Margin | -82.5% | -12.6% | -69.9% |
| ROE | -19.1% | -39.2% | +20.1% |
| ROA | -15.6% | -30.9% | +15.4% |
| Current Ratio | 7.88 | 2.73 | +5.15 |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -15.6% | — |
| ✗Flujo de caja operativo positivo | −₪33M | −₪41M |
| ✓Rentabilidad sobre activos al alza | -15.6% | -25.9% |
| ✗Caja operativa/activos supera al ROA | -32.3% | ROA -15.6% |
| –Menos deuda a largo plazo | — | — |
| ✗Mejor liquidez (ratio corriente) | 7.88 | 9.28 |
| ✗Sin aumentar el nº de acciones | 6M | 6M |
| ✓Margen bruto al alza | 84.2% | 37.0% |
| ✓Rotación de activos al alza | 0.39 | 0.07 |
| Calidad del negocio | FY25 |
|---|---|
| ✗Margen FCF > 10 % | -82.5% |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 43.7% |
Pulsenmore Ltd. cotiza a 1.87 USD y tiene una capitalización bursátil de $12M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud